Susana de la Cruz Sánchez-rekin lankidetzan egindako argitalpenak (2)

2020

  1. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

    The Lancet Oncology, Vol. 21, Núm. 4, pp. 519-530

2010

  1. Adjuvant endocrine therapy in premenopausal women with breast cancer

    Breast Cancer Research and Treatment, Vol. 123, Núm. SUPPL. 1, pp. 43-47